Cite
HARVARD Citation
Xu, Q. et al. (2021). Design and optimisation of a small-molecule TLR2/4 antagonist for anti-tumour therapy. RSC medicinal chemistry. 12 (10), pp. 1771-1779. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xu, Q. et al. (2021). Design and optimisation of a small-molecule TLR2/4 antagonist for anti-tumour therapy. RSC medicinal chemistry. 12 (10), pp. 1771-1779. [Online].